177 related articles for article (PubMed ID: 10831065)
1. Modifications of whole blood filterability during acute myocardial infarction.
Penco M; Romano S; Dagianti A; Tozzi-Ciancarelli MG; Dagianti A
Clin Hemorheol Microcirc; 2000; 22(2):153-9. PubMed ID: 10831065
[TBL] [Abstract][Full Text] [Related]
2. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
3. [Erythrocyte filtration in acute myocardial infarction].
Barbera CM; Arrigo F; Giannetto M; Consolo F
Ric Clin Lab; 1983; 13 Suppl 3():405-9. PubMed ID: 6673021
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.
Mannini L; Marcucci R; Paniccia R; Antonucci E; Giglioli C; Valente S; Gori AM; Prisco D; Gensini GF; Abbate R
Clin Hemorheol Microcirc; 2006; 35(1-2):175-81. PubMed ID: 16899924
[TBL] [Abstract][Full Text] [Related]
5. Acute myocardial infarction in young adults: evaluation of the haemorheological pattern at the initial stage, after 3 and 12 months.
Caimi G; Valenti A; Lo Presti R
Ann Ist Super Sanita; 2007; 43(2):139-43. PubMed ID: 17634662
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
[TBL] [Abstract][Full Text] [Related]
7. [Whole blood viscosity measurement in acute myocardial infarction: feasibility and significance].
Philippe F; Lacombe C; Bucherer C; Drobinski G; Montalescot G; Thomas D
J Mal Vasc; 2001 Oct; 26(4):243-7. PubMed ID: 11679853
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
[TBL] [Abstract][Full Text] [Related]
9. Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy.
Cecchi E; Marcucci R; Paniccia R; Bandinelli B; Valente S; Giglioli C; Lazzeri C; Gensini GF; Abbate R; Mannini L
Am J Cardiol; 2009 Sep; 104(6):764-8. PubMed ID: 19733708
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction.
Kosmala W; Przewlocka-Kosmala M; Mazurek W
Int J Cardiol; 2005 Jun; 101(3):449-56. PubMed ID: 15907414
[TBL] [Abstract][Full Text] [Related]
11. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrheological changes in ischemic heart disease].
Forconi S; Guerrini M; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():195-208. PubMed ID: 6672996
[TBL] [Abstract][Full Text] [Related]
13. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
15. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.
Toth K; Bogar L; Juricskay I; Keltai M; Yusuf S; Haywood LJ; Meiselman HJ
Clin Hemorheol Microcirc; 1997; 17(2):117-25. PubMed ID: 9255435
[TBL] [Abstract][Full Text] [Related]
16. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
[TBL] [Abstract][Full Text] [Related]
17. Haemorheological parameters in young patients with acute myocardial infarction.
Zorio E; Murado J; Arizo D; Rueda J; Corella D; Simó M; Vayá A
Clin Hemorheol Microcirc; 2008; 39(1-4):33-41. PubMed ID: 18503108
[TBL] [Abstract][Full Text] [Related]
18. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
19. [Hemorheologic parameters during the 6 months following myocardial infarct].
Tóth K; Mezey B; Juricskay I; Simor T; Jávor T
Orv Hetil; 1990 Apr; 131(14):727-30. PubMed ID: 2183141
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell deformability in diabetes mellitus: effect of phytomenadione.
Sabo A; Jakovljević V; Stanulović M; Lepsanović L; Pejin D
Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):1-5. PubMed ID: 8444511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
